CERES INC. Logo

CERES INC.

Develops online media platforms connecting consumers with advertisers through a rewards system.

3696 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
渋谷区桜丘町1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ceres Inc. is an internet marketing company operating under the mission of "Enriching the world through internet marketing." The company's core business involves the development and management of online media platforms. Its flagship service is "Moppy," a point media site where users can accumulate points through various online activities and exchange them for rewards. By connecting a large consumer base with advertisers, Ceres provides marketing and user acquisition solutions for businesses while offering value to its platform users.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 05:30
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-08-13 05:29
Interim Report
半期報告書-第21期(2025/01/01-2025/12/31)
Japanese 228.9 KB
2025-07-18 08:49
M&A Activity
臨時報告書
Japanese 22.5 KB
2025-07-01 08:56
Major Shareholding Notification
大量保有報告書
Japanese 34.4 KB
2025-05-08 09:40
Regulatory News Service
臨時報告書
Japanese 19.1 KB
2025-04-21 09:17
Share Issue/Capital Change
臨時報告書
Japanese 30.8 KB
2025-03-26 06:24
Governance Information
内部統制報告書-第20期(2024/01/01-2024/12/31)
Japanese 23.2 KB
2025-03-26 06:18
Registration Form
確認書
Japanese 8.1 KB
2025-03-26 06:10
Annual Report
有価証券報告書-第20期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-03-26 05:15
Post-Annual General Meeting Information
臨時報告書
Japanese 24.6 KB
2025-02-14 09:14
Regulatory News Service
臨時報告書
Japanese 19.7 KB
2025-02-14 09:14
Regulatory News Service
臨時報告書
Japanese 18.0 KB
2025-01-27 09:12
Regulatory News Service
臨時報告書
Japanese 22.6 KB
2024-08-13 08:58
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-08-13 08:57
Interim Report
半期報告書-第20期(2024/01/01-2024/12/31)
Japanese 197.3 KB

Automate Your Workflow. Get a real-time feed of all CERES INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CERES INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.